Using D9 cells, we identified several genes involved in the inflammasome pathway, such as AIM2, IL1B, and CASP1, as downstream targets of JAK2V617F, which could explain the molecular mechanism behind myelofibrosis development in patients harboring the JAK2V617F mutation. This evidence concerns the gene AIM2 and myelofibrosis.